Results of the Treatment of 400 Cases of Lobar Pneumonia with M & B 693
By WILFRID F. GAISFORD, M.D., M.R.C.P.
Physician to Dudley Road Hospital, Birmingham IN a previous publication (1938) Dr. Evans and I reported our results after three months' trial of M & B 693 in cases of lobar pneumonia. 100 cases had then been treated and in the succeeding nine months another 300 cases have been added to these.
Altogether nearly 700 cases of respiratory infection have been treated with M & B 693 at Dudley Road Hospital, Birmingham, since March 1938, and the following is a brief account of our results with the 400 cases of lobar pneumonia included therein.
It was appreciated by Dr. Evans and myself that our paper was only a preliminary one and that it was unwise to draw any conclusions from such a small series of cases, particularly in a disease like pneumonia in which one often encounters a run of a score or more cases with no fatalities. Furthermore, we had used the drug over such a limited period of time and that time April, May, and June, which might have coincided with a mild type of infection.
It is true that we were able to rule out the last because our control cases showed a mortality of 27% compared with 8% in the treated cases. We had only three types of pneumococci for determining which was the infecting organism, all others being included as group IV, and we made no investigations into the blood concentration of the drug or its mode or rate of excretion. Since October the thirty types have been used and typing of the pneumococci in the sputum has been undertaken whenever possible. X-rays have been employed as a routine during this time instead of just in doubtful cases as at first. The diagnosis " lobar pneumonia " has been based throughout on the same essentials as originally, viz. a history of sudden onset, rigor or vomiting, fever, pain in the side of the chest, cough, often with rusty sputum, and physical signs of consolidation in the lung.
No attempt has been made to divide the cases into " mild " and " severe ", and admittedly most of the former would have recovered in any case, but for fair comparison the hospital figures for the preceding two years are offered. The patients have been drawn from the same sources and treated by the same physicians using identical criteria of diagnosis throughout.
Children under the age of 5 are not included so as to avoid any controversial differential diagnoses between broncho-and lobar pneumonia and because they form a fitting subject for separate consideration.
Also Table III shows briefly details of the 26 fatal cases. Those which are starred are ones on which post-mortems were held, just over half of them.
Seven of them were reported amongst our first 100 cases and the first five admittedly had insufficient dosage-no more than we give to an infant now.
Most of the others, as will be seen, had some complication or other. The types are known in eleven (and two of the first five were group IV); one was a Friedlander and one grew nothing (No. 8).
These deaths refer to the pneumococcal lobar pneumonias only. We have had three deaths from staphylococcal (one of which was included in our first 100 cases but is excluded here), and two from streptococcal pneumonias and one diagnosed as a right upper lobe pneumonia who showed no response to M & B 693 was found at It is almost certain that some of the 1936 and 1937 deaths were streptococcal or staphylococcal, but I have not been able to find out the exact number because our attention was not focused at that time on the bacteriology of our pneumonias.
By comparison with the later cas&es, if we allow that 2% were non-pneumococcal that would bring the figures into line. It makes the 1936 mortality 21% and the 1937 20% to compare with 6-5% in the treated cases.
The Effects of the Drug.
First on the temperature. We have found in nearly all cases a prompt drop to normal within forty-eight hours of starting treatment, irrespective of the day of the disease. Continued pyrexia after the full course of M & B 693 has indicated either the presence of some complication or more frequently, that the infecting organism is not a pneumococcus.
Second on the physical signs. I have not been able to determine any alteration in the rate of resolution: in some cases it seems actually to have been delayed though not to any marked extent.
Third on the patient. A-gradual-yet fairly rapid improvemeita takes place in the general condition following the fall in temperature, not so striking as at the normal crisis, but nevertheless clearly evident. The mental depression which is a characteristic sequela of the sulphanilamide group generally-has been observed in a number of cases but persists for a very short while.
Complications of the Disease.
In addition to the six empyemas we had in our first 100 cases there have been 12' others, one staphylococcal (who had type I pneumococci in the sputum) and 11 pneumococcal, 10 type I and one type II, this predominance of type I being in accord with other peoples' findings. There were also two synpneumonic empyemas who died; both tvpe I.
In addition we have had four cases of clear sterile effusions, presumably aborted empyemas, which have delayed convalescence considerably. Another clear effusion was found at autopsv in a type XVII pneumonia. X-rays showed fluid at the base in two more cases but spontaneous absorption occurred.
In the 461 cases in 1937 there were 30 empyemas, so the incidence does not appear to have increased, as we at first thought it might.
Complications of the Drug.
Possibly because our experience is still very limited, possibly because we have been lucky, our complications have only been minor ones. For example we have had no cases of anaemia or granulopenia and have found no evidence of kidney or liver damage either during life or at post-mortem. This applies not only to the 400 cases under discussion but to all the patients who have received M & B 693.
We had the opportunity of seeing one case at autopsy six months after he had recovered from pneumonia having died after falling downstairs-and an extensive examination by Dr. Whitelaw, the hospital pathologist, failed to reveal any evidence of residual toxic effects.
Seeing that all the drug is excreted at least from the blood and urine-within forty-eight hours of discontinuing treatment, this is not surprising.
We have, of course, seen a number of rashes, and these have been similar in character to the sulphanilamide rash though less severe, and in allergic patients have forsaken the usual morbilliform type and become frankly urticarial.
Commonly the rash arises during treatment, but may be delayed till two or three days after treatment has ceased. It is independent of the amount of drug given and disappears in the course of a few days.
Cyanosis-.We still see this in a number of cases, but it has ceased to be a worrying sign. It disappears promptly, like the rash, when treatment is discontinued. Cyanosis already existing is not a contra-indication to prescribing M & B 693 and may be treated by oxygen or venesection in the usual manner.
Vomiting. In babies and young children vomiting after M & B 693 is practically non-existent. Unfortunately, as everyone has found, such is not the case among adults.
In view of the fact that we believe that large initial doses give the best results this vomiting becomes an important consideration. It is sometimes extremely difficult to overcome. Occasionally it is psychological but more often dependent on the presence of gastritis, either due to the infection, or pre-existing. It is not of central origin, nor is it due to variations in the tablets as we at first thought might be the case, as these now consist of the pure drug in compressed form and contain no acid extractive as did those we used originally.
Some patients undoubtedly take the tablets better when they are crushed and suspended in water or hot or cold milk; others can swallow them whole without upset. If coughing causes vomiting they may be given suspended in a linctus.
When vomiting does occur the next dose should be given by a different method, e.g. if vomited when given whole they should be crushed and suspended next time.
Some patients can take smaller doses, e.g. one tablet at hourly intervals, and this method is worth trying if the others fail.
It has been my experience that only rarely is the vomiting so persistent that ani insufficient amount of the drug is retained, but in such cases a parenteral method of administration is desirable.
We have for some weeks past now been using solutions of the sodium salt of M & B 693 both by intravenous and intramuscular injections.
It is too early yet to give details of our investigations and findings, but I can say that while the intravenous results are not yet satisfactory the intramuscular route has proved highly so, being free from reaction, not giving rise to vomiting, no more toxic than M & B 693 given orally, and producing results as good or better. We have not yet determined what strength solution, dose, or interval, is optimal. We are investigating the blood concentrations attained and the rate and mode of excretion, but it will be some time before our results will be ready for publication.
Dosage.-In general we adhere to our originally suggested dose of four tablets (2 grm.) on admission and two tablets four-hourly thereafter till the temperature falls, and then one thrice daily for twenty-four to forty-eight hours. This last is to obviate the secondary rise of temperature which occurs if treatment be stopped too soon and which has been shown to be due to a direct spread of the disease process in the affected lobe.
In milder cases two tablets four-hourly will usually suffice, while in severe cases I give four tablets four-hourly for four doses, giving 8 grm. in the first twelve hours after admission and then continue with two tablets four-hourly.
This saturation of the system in the first few hours has the advantage of allowing what is often a much-needed sedative to be given, and subsequent doses are omitted till the patient rouses.
The non-specific treatment of these pneumonias has consisted in good nursing, as much fresh air as possible, fluids freely, frequent mouth-washes, adequate attention to the bowels, Gee's linctus, and morphia after the intensive treatment is finished if sleeplessness is a worrying symptom.
Typing.-Typing of the pneumococci from the sputum has been done in rather -more than half the cases but, as has been said, we have been using the 30 types only since October, so our figures are still too small to be of great value.
Dr. Whitelaw reported that he was unable to assign any type number to some of the specimens he received, but Table IV shows such results as we have obtained to date. Lung puncture has not been employed. To sum up, it may be said that M & B 693 represents a real advance in the treatment of lobar pneumonia, and the improvement in results is comparable with that seen in streptococcal infections since the introduction of sulphanilamide. well-marked immunity response (probably far greater than would be effective in combination with M & B 693) is manifest in some three days after a single dose of pneumococcal vaccine. This being so there was every likelihood although it had yet to be proven that in a far shorter time sufficient immunity would have developed to have a marked result on pneumococci affected by the administration of M & B 693. Some physicians believed in simple vaccine treatment of pneumonia, and there were some who have used it for many years as a routine procedure. The advent of M & B 693 seemed to him likely in the long run to greatly increase the number who adopt this method in combination with chemotherapy.
Another aspect of the subject which might have some bearing on the failures of treatment by M & B 693 was the acquired tolerance or fastness of pneumococci to the drug. Maclean, Rogers and Prof. Fleming himself had recently published evidence that pneumococci could, in animals, rapidly become tolerant to M & B 693. In the last few days they had been doing experiments with two cultures of pneumococci which were sent to them from New Guinea by Dr. Backhouse. These were both pneumococcus type I; the first was isolated from a patient just after M & B 693 treatment was commenced, and the second was isolated from the same patient 33 days afterwards at the post-mortem. During this time the patient had received 28-5 gri. of M & B 693. When they tested these two cultures for sensitivity to M & B 693 they found that the first was moderately sensitive but the second was extremely insen-sitive. The simplest explanation of this case was that the patient did not have sufficient immunity to deal with the pneumococci even after they had been subject to a, high concentration of M & B 693. The treatment therefore did not save the patient buit it was evident that it immunized the pneumococci to the drug.
Dr. H. Stanley Banks said that in the Park Hospital recently about 30 cases of pneumonia in adults had been typed and treated with M & B 693. Types I, II, III, IV, VI, V-II, VIII, X, XXI, and XXIII, were represented. The cases were mostly middle-aged or elderlv persons. He had been impressed with the absence of mortality so far in this small series of unpromising prognosis. The sodium solution of the drug had been used intramuscularly to replace the oral administration of tablets when vomiting made it necessary. He thought that the sodium solution w-as less toxic than was at first supposed, and that it should be used in not less than half the dosage, weight for weight of that applicable to the tablets. The inci(lence of empyema in treated cases of pneumonia appeared high. He had found that the content of the drug in the pleural pus was frequently higher than that in the blood, and, in spite of this, the organism could be cultured day after day from the aspirated pus. This applied even when the diluted sodium solution was injected into the pleural cavity and the content of the drug therein maintained at very high levels suchi as 80 to 100 mgm.0,. He asked Dr. Whitby if it were known that the pneumococcus might become insensitive to M & B 693 under these conditions. Dr. Maurice Davidson said that, while the valuie of M & B 693 wN-as universally admitted, it was desirable to make some protest against the indiscriminate use of this and other preparations of the sulphanilamide group. Apart from the fact that wholesale administration of such drugs in various febrile conditions, without a certain diagnosis and without scientific control, was wrong in principle, he felt that a risk might be entailed of dainage to vital organs of the body. He would like to ask the chief speakers whether there w-as any evidence of delayed after-effect of M & B 693 and allied drugs, e.g. damage to the renal epithelium or to the myocardium.
Dr. Whitby in reply, said that the drug might well be ineffective in a miedlium such as pus. Laboratory experiments clearly showed that the action of these drugs was sometinmes inhibited by the presence of certain proteins. With regard to Dr. Davidson's quiery, there wNas no evidence to this effect, no stuch delayed after-effect had nowbeen reportedl.
